Understanding the side effects of chronic silodosin administration via untargeted metabolomics approach.

IF 1 Q4 PHARMACOLOGY & PHARMACY Annales pharmaceutiques francaises Pub Date : 2024-08-08 DOI:10.1016/j.pharma.2024.08.002
Tugrul Cagri Akman, Yucel Kadioglu, Onur Senol, Beyzagul Erkayman, İsmail Cagri Aydin
{"title":"Understanding the side effects of chronic silodosin administration via untargeted metabolomics approach.","authors":"Tugrul Cagri Akman, Yucel Kadioglu, Onur Senol, Beyzagul Erkayman, İsmail Cagri Aydin","doi":"10.1016/j.pharma.2024.08.002","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Precision medicine, which looks for high efficacy and low toxicity in therapies, has increased in popularity with omics technology. This work aims to discover novel and low-toxicity therapy options by examining the complex relationship between silodosin-induced side effects and the metabolomic profiles associated with its administration.</p><p><strong>Materials and methods: </strong>The plasma samples of the control group and silodosin-treated rats were analyzed by LC-Q-TOF-MS/MS. Employing XCMS and MetaboAnalyst software, MS/MS data processed to detect compounds and investigate metabolic pathways. MATLAB 2019b was used for data categorization and multivariate analysis. A thorough comparison of METLIN and HMDB databases revealed 41m/z values with significant differences between the drug-treated and control groups (p <0.01 and fold analysis≥1.5).</p><p><strong>Results: </strong>According to multivariate data analysis, 17-β-estradiol, taurocholic acid, L-kynurenine, N-formylkynurenine, D-glutamine, L-arginine, prostaglandin H2, prostaglandine G2, 15-keto-prostaglandin E2, calcidiol, thromboxane A2, 5'-methylthioadenosine, L-methionine and S-adenosylmethionine levels changed significantly compared to the control group. Differences in the metabolisms of glycerophospholipid, tyrosine, phenylalanine, arachidonic acid, cysteine and methionine, and biosynthesis of phenylalanine, tyrosine, and tryptophan, and aminoacyl-tRNA have been successfully demonstrated by metabolic pathway analysis. According to this study, vitamin D, D-glutamine, and L-arginine supplements can be recommended to prevent side effects such as fatigue, intraoperative floppy iris syndrome, blurred vision, and dizziness in the treatment of silodosin. Silodosin treatment negatively affected the immune system by affecting the kynurenine and tryptophan metabolism pathways.</p><p><strong>Conclusions: </strong>The study is a guide for silodosin treatments that offer low side effects and high therapeutic effect within the scope of precision medicine.</p>","PeriodicalId":8332,"journal":{"name":"Annales pharmaceutiques francaises","volume":null,"pages":null},"PeriodicalIF":1.0000,"publicationDate":"2024-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annales pharmaceutiques francaises","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.pharma.2024.08.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Precision medicine, which looks for high efficacy and low toxicity in therapies, has increased in popularity with omics technology. This work aims to discover novel and low-toxicity therapy options by examining the complex relationship between silodosin-induced side effects and the metabolomic profiles associated with its administration.

Materials and methods: The plasma samples of the control group and silodosin-treated rats were analyzed by LC-Q-TOF-MS/MS. Employing XCMS and MetaboAnalyst software, MS/MS data processed to detect compounds and investigate metabolic pathways. MATLAB 2019b was used for data categorization and multivariate analysis. A thorough comparison of METLIN and HMDB databases revealed 41m/z values with significant differences between the drug-treated and control groups (p <0.01 and fold analysis≥1.5).

Results: According to multivariate data analysis, 17-β-estradiol, taurocholic acid, L-kynurenine, N-formylkynurenine, D-glutamine, L-arginine, prostaglandin H2, prostaglandine G2, 15-keto-prostaglandin E2, calcidiol, thromboxane A2, 5'-methylthioadenosine, L-methionine and S-adenosylmethionine levels changed significantly compared to the control group. Differences in the metabolisms of glycerophospholipid, tyrosine, phenylalanine, arachidonic acid, cysteine and methionine, and biosynthesis of phenylalanine, tyrosine, and tryptophan, and aminoacyl-tRNA have been successfully demonstrated by metabolic pathway analysis. According to this study, vitamin D, D-glutamine, and L-arginine supplements can be recommended to prevent side effects such as fatigue, intraoperative floppy iris syndrome, blurred vision, and dizziness in the treatment of silodosin. Silodosin treatment negatively affected the immune system by affecting the kynurenine and tryptophan metabolism pathways.

Conclusions: The study is a guide for silodosin treatments that offer low side effects and high therapeutic effect within the scope of precision medicine.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
通过非靶向代谢组学方法了解长期服用西洛多辛的副作用
背景:精准医疗(precision medicine)是一种追求高效、低毒的治疗方法,随着omics技术的发展而越来越受欢迎。本研究旨在通过了解西洛多辛引起的副作用与用药相关代谢组学特征之间的复杂关系,发掘创新的低毒性疗法:采用 LC-Q-TOF/MS/MS 分析对照组和西洛多辛治疗组大鼠的血浆样本。采用 LC-Q-TOF-MS/MS 分析对照组和西洛多辛治疗组大鼠的血浆样本。利用 XCMS 和 MetaboAnalyst 软件处理 MS/MS 数据,以检测化合物并研究代谢途径。MATLAB 2019b 用于数据分类和多元分析。通过全面比较 METLIN 和 HMDB 数据库,发现药物治疗组和对照组之间有 41 个 m/z 值存在显著差异(pResults:根据多元数据分析,与对照组相比,17-β-雌二醇、牛胆酸、L-犬尿氨酸、N-甲酰犬尿氨酸、D-谷氨酰胺、L-精氨酸、前列腺素 H2、前列腺素 G2、15-酮前列腺素 E2、降钙素二醇、血栓素 A2、5'-甲硫基腺苷、L-蛋氨酸和 S-腺苷蛋氨酸的水平发生了显著变化。通过代谢途径分析,成功证实了甘油磷脂、酪氨酸、苯丙氨酸、花生四烯酸、半胱氨酸和蛋氨酸的代谢以及苯丙氨酸、酪氨酸、色氨酸和氨基酰-tRNA的生物合成存在差异。根据这项研究,建议补充维生素 D、L-谷氨酰胺和 L-精氨酸,以防止西洛多辛治疗过程中出现疲劳、术中虹膜松弛综合征 IFIS、视力模糊和头晕等副作用。西洛多辛治疗通过影响犬尿氨酸和色氨酸代谢途径对免疫系统产生负面影响:该研究为西洛多辛治疗提供了指导,在精准医疗的范围内,西洛多辛治疗可提供低副作用和高疗效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Annales pharmaceutiques francaises
Annales pharmaceutiques francaises PHARMACOLOGY & PHARMACY-
CiteScore
1.70
自引率
7.70%
发文量
98
期刊介绍: This journal proposes a scientific information validated and indexed to be informed about the last research works in all the domains interesting the pharmacy. The original works, general reviews, the focusing, the brief notes, subjected by the best academics and the professionals, propose a synthetic approach of the last progress accomplished in the concerned sectors. The thematic Sessions and the – life of the Academy – resume the communications which, presented in front of the national Academy of pharmacy, are in the heart of the current events.
期刊最新文献
[Lipoprotein-associated phospholipase A2 (Lp-PLA2) : relevant biomarker and therapeutic target?] Editorial board Urinary cytomegalovirus excretion: The unresolved issues Trace level quantification of N-nitrosorasagiline in rasagiline tablets by LC-TQ-MS/MS A UPLC method development and validation study of Upadacitinib and its impurities in extended – release oral tablet dosage forms
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1